Home
SERB Pharmaceuticals

SERB Pharmaceuticals Market Share Analysis for February 2026

Take a few minutes to watch our quick, informative video on the dangers of fire smoke and cyanide poisoning and what you can do to protect yourself and your loved ones in the event of a life-threatening emergency.

Health > Biotechnology and Pharmaceuticals

Domainserb.com

Year Founded1950

Employees201 - 500

Annual Revenue$10M - $15M

SERB Pharmaceuticals

SERB Pharmaceuticals (including company regionals)

serb.com

See more website traffic and engagement information

SERB Pharmaceuticals Revenue up to February 2026 is 10M - 15M

revenue generated by SERB Pharmaceuticals top domains

SERB Pharmaceuticals top domains revenue over 3 years

Revenue for SERB Pharmaceuticals top domains

serb.com10M - 15M

See more with Sales Intelligence

Total visits to SERB Pharmaceuticals's top domains

Understand SERB Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

serb.com11.8K

See more with Sales Intelligence

Avg. visit duration in SERB Pharmaceuticals's top domains

Analyze SERB Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

serb.com00:00:55

See more with Sales Intelligence

Avg. pageviews on SERB Pharmaceuticals's top domains

See how SERB Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

serb.com1.71

See more with Sales Intelligence

SERB Pharmaceuticals top competitors by domain

Top similar sites in February 2026, ranked by their affinity

cheplapharm.comCompany NameCheplapharm AGEmployees501 - 1000HQGermany, GreifswaldAnnual revenue$15M - $25MTotal visits22.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by SERB Pharmaceuticals

These are the website technologies, by industry, used by SERB Pharmaceuticals top domains

Advertising (2)

Google Adsense

Email Services (2)

Rackspace MailGun

Mobile (2)

Meta Viewport

Widget (2)

Twemoji

More Technologies

8

See all

News & Signals from SERB Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSERB Pharmaceuticals acquired Y-mAbs for $412M on Sep 16th '25.West Conshohocken, PA, Sept. 16, 2025 (GLOBE NEWSWIRE) - SERB Pharmaceuticals ("SERB"), a global specialty pharmaceutical company focused on rare diseases and medical emergencies, today announced the successful completion of its acquisition of Y-mAbs Therapeutics, Inc. ("Y-mAbs"), a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the treatment of cancer.

NewsSERB Pharmaceuticals is planning to acquire Y-mAbs for $412M.SERB pharmaceuticals to acquire Y-mAbs therapeutics for $412 million.

NewsEmergent Testing, LLC sells assets to SERB Pharmaceuticals in the amount of $75M.Emergent BioSolutions Inc. (NYSE: EBS) has sold its RSDL(R) (Reactive Skin Decontamination Lotion) kit to SERB Pharmaceuticals for $75 million, with an additional $5 million milestone payment potential.